Cadila Healthcare informs about company updates

06 Dec 2019 Evaluate

Cadila Healthcare has informed about inspection by USFDA of the company’s API manufacturing facility located at Dabhasa, Gujarat and company received an Establishment Inspection Report (EIR) which stated that the classification of the facility is ‘No Action Indicated (NAI)’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

925.95 -10.35 (-1.11%)
19-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1525.00
Dr. Reddys Lab 5942.65
Cipla 1345.35
Zydus Lifesciences 925.95
Lupin 1547.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.